This playbook examines how pharmaceutical supply chains are evolving through AI, machine learning, sustainability initiatives, and supplier collaboration. Developed by LogiPharma and Blue Yonder, the report presents survey findings from global pharmaceutical supply chain leaders on digital transformation priorities, AI adoption, ROI expectations, and sustainability strategies. The playbook highlights that AI and machine learning are becoming central to pharmaceutical operations, particularly in forecasting, inventory optimization, visibility, and customer service, while many organizations are still in the early stages of AI maturity. It also emphasizes the growing importance of measurable sustainability goals, net-zero initiatives, and collaborative supplier ecosystems. The report position

Join for free to read